Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin

Melanoma Research

Volumn 13, Issue 4, 2003, Pages 365-370

  Dȩbniak, Tadeusz ^a   Górski, Bohdan ^a   Cybulski, Cezary ^a   Jakubowska, Anna ^a   Kurzawski, Grzegorz ^a   Lener, Marcin ^a   Mierzejewski, Marek ^a   Masojć, Bartosz ^a   Mȩdrek, Krzysztof ^a   Kładny, Józef ^a   Załuga, Elzbieta ^a   Maleszka, Romuald ^a   Chosia, Maria ^a   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Breast cancer; Malignant melanoma; NBS1 gene mutation

Indexed keywords

GENOMIC DNA;

ALLELE; ARTICLE; BREAST CANCER; CHROMOSOMAL LOCALIZATION; CHROMOSOME 8Q; CONTROLLED STUDY; EXON; EYE TUMOR; GENE; GENE MUTATION; HAPLOTYPE; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; NBS1 GENE; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; COMORBIDITY; DNA, NEOPLASM; FEMALE; FOUNDER EFFECT; GENETICS, POPULATION; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEAR PROTEINS; PEDIGREE; POLAND; PREVALENCE; RANDOM ALLOCATION; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS;

EID: 17144442945     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200308000-00005     Document Type: Article

References (25)

1. Goldstein AM, Tucker MA. Genetic epidemiology of familial melanoma. Dermatol Clin 1995; 13:605-612.
2. Greene MH. The genetics of hereditary melanoma and nevi. 1998 update. Cancer 1999; 86 (suppl 11):2464-2477.
3. Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry D IV, Sagebiel R, et al. Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res 2002; 12:51-55.
4. Spatz A, Giglia-Mari G, Benhamou S, Sarasin A. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res 2001; 61:2480-2486.
5. Digwed M. Human genetic instability syndromes: single gene defects with increased risk of cancer. Toxicol Lett 1993; 67:259-281.
6. Araujo FD, Pierce AJ, Stark JM, Jasin M.Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene 2002; 21:4176-4180.
7. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998; 83:467-476.
8. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR III, et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998; 93:477-486.
9. Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 2000; 8:900-902.
10. 2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 1993; 31:321-328.
11. Ren ZP, Sallstrom J, Sundstrom C, Nister M, Olsson Y. Recovering DNA and optimizing PCR conditions from microdissected formalin-fixed and paraffin-embedded materials. Pathobiology 2000; 68:215-217.
12. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J Am Med Assoc 1995; 273:558-563.
13. Cerosaletti KM, Morrison VA, Sabath DE, Willerford DM, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2002; 36:282-286.
14. Varon R, Gosse-Brun S, Bignon YJ, Sperling K, Uhrhammer N. Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma. Oncol Rep 2002; 9:709-711.
15. Futaki M, Liu JM. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med 2001; 7:560-565.
16. Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV. Cancer risks in women with 2 breast or ovarian cancers: clues to genetic cancer susceptibility. Int J Cancer 2001; 94:758-759.
17. Hemminki K, Lonnstedt I, Vaittinen P. A population-based study of familial cutaneous melanoma. Melanoma Res 2001; 11:133-140.
18. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994; 8:22-26.
19. Scott RJ, Vajdic CM, Armstrong BK, Ainsworth CJ, Meldrum CJ, Aitken JF, et al. BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer 2002; 102:188-191.
20. Iscovich J, Abdulrazik M, Cour C, Fischbein A, Pe'er J, Goldgar DE. Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 2002; 98:42-44.
21. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000; 60: 5612-5616.
22. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92:1260-1266.
23. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265:2088-2090.
24. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002; 11:1399-1407.
25. Steffen J, Varon R, Thomas M, Maurer M, Stumm M, Nowakowska D, et al. The frequency of heterozygous germline NBS1 mutation 657del5 in cancer patients from Poland. International Workshop on Nijmegen Breakage Syndrome, Prague, 25-28 April 2002, Czech Republic.